Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation
about
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessmentComplement in Lupus Nephritis: New PerspectivesSystemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical PathwayCrystal Structure of C5b-6 Suggests Structural Basis for Priming Assembly of the Membrane Attack ComplexUse of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatmentIn vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzeesComplement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia.Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patientsAltered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.Complement and systemic lupus erythematosus.Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18).Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuriaThe presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon.In vivo binding of circulating immune complexes by C3b receptors (CR1) of transfused erythrocytes.Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1.Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor.A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.Dual role of erythrocyte complement receptor type 1 in immune complex-mediated macrophage stimulation: implications for the pathogenesis of Plasmodium falciparum malaria.Complement in cancer: untangling an intricate relationship.Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise.Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35).C1q and Mannose-Binding Lectin Interact with CR1 in the Same Region on CCP24-25 Modules.Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surfaceInherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease
P2860
Q24675466-301CFDE3-065E-4D2D-A920-66E0AE4B0A9BQ26740491-125985FF-A044-46DF-9431-03B5B35784B9Q26768534-6343D21D-08D9-4CE3-8DDA-37B8E8D685A6Q27678501-59AD4F26-8882-45F8-9ED0-EED707C0DAD1Q30445571-8AF0C433-5334-4B3C-9B65-D0F109FE0ECFQ30449835-2CACC035-6AF2-410B-A8D2-43B228CA41A5Q30452831-CF7A8F71-8B9B-45CD-839F-C7DB4AE0B140Q30847354-7558240C-EA6F-443D-9FE7-669C2A838A9FQ33867535-08DFD4E2-B8A6-480A-A094-3B25CF882040Q33902027-0B484C41-9EDF-465C-87CA-F4885B4E5271Q34542184-122B4DF1-7741-4BFC-800F-69BE3FF20AD4Q34731255-A0169E2D-A60C-42E0-8BDB-6DC069DE6483Q35595003-FBCA50A0-E310-424A-93A3-28573D5B9882Q35868877-375F3D47-322A-481F-9944-9960145617D7Q36283294-0F88A7F8-0B38-4DE6-8808-CC0F9BB674A3Q37552016-28BABBBA-852F-47FF-AA2F-942E1C4C2B04Q37558525-3944834D-EA7C-4309-8C54-AB7BF368405DQ41206981-09242365-BF5E-41BE-8C7D-7FA2EFE1584EQ41241329-DA359945-342A-493E-9281-6F1C69E8D2F0Q42853453-F894A965-F575-4175-A291-4281A1F0B04AQ46938672-5914D9FD-0857-4A7E-AB95-07D1ECAF8739Q47992165-7004F2A9-7308-479E-AFF8-761653D714F3Q50049007-3E245EB4-6370-4996-8F6D-F92E5D8700C2Q50660840-15180A9B-A111-40DC-B8AD-74B308690FF3Q50695228-CE7B8618-7D4C-43E9-B397-C0C00D2C9406Q52643677-9DD58B69-B5E6-440B-9877-14944F07E888Q53640783-46144172-32B5-42BB-94A3-E775808A0955Q57089819-DEC5B7DA-2585-497D-B505-10973F17B123Q57600872-4901746D-EF5A-4796-9FC0-07AA742A10B8
P2860
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation
description
im September 1985 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 1985
@uk
name
Disease-associated loss of ery ...... s and/or complement activation
@en
Disease-associated loss of ery ...... s and/or complement activation
@nl
type
label
Disease-associated loss of ery ...... s and/or complement activation
@en
Disease-associated loss of ery ...... s and/or complement activation
@nl
prefLabel
Disease-associated loss of ery ...... s and/or complement activation
@en
Disease-associated loss of ery ...... s and/or complement activation
@nl
P2093
P1476
Disease-associated loss of ery ...... s and/or complement activation
@en
P2093
B L Myones
C J Parker
C R Fuller
J B Winfield
M J Walport
P J Lachmann
R P Taylor
P304
P407
P577
1985-09-01T00:00:00Z